"Revlimid" (lenalidomide) analogues price. Dị ka dị ọnụ ala karịa ịzụta a "Revlimid" 25 mg?

Ka anyị tụlee ndị mbụ ọnọdụ - i nwere oké nsogbu ahụ ike, na mkpa maka ọgwụ ọjọọ na-amụba na onye ọ bụla na-agafe n'ụbọchị. Ma ọ bụrụ na ị bụghị a nnọọ ọgaranya, ma e wezụga, na oge a ka na-adịghị nnọọ dimkpa, ọ bụ nnọọ ekwe omume na-esote zuo pụtara na ị pụrụ ịgakwuru a oké nsogbu. Gịnị na-eme? Ebe a na-abịa nnapụta na generics.

Ọnyà - a ọgwụ na-enwe kpọmkwem otu mejupụtara na arụmọrụ dị ka mara na n'okpuru ika n'aka, ma uru nke ukwuu dị ọnụ ala karịa. Otu n'ime ndị a ọgwụ ọjọọ eme ihe na-anọchi anya a ọhụrụ na klas nke immunomodulators na-arụpụtara ke India site Natco Pharma Ltd. ukara ọnyà ọgwụ ọjọọ, "Revlimid» - Lenalid.

Ya isi nọ n'ọrụ umi - lenalidomide - ngosi e wezụga immunomodulatory, gosikwara antiangiogenic mmetụta.

Ka anyị anya na ojiji nke ọgwụ ọjọọ, "Revlimid" na ya kasị ewu ewu na ụbọchị ọnyà.

Ebe m nwere ike ịzụta a ọnyà "Revlimid"

Generics, n'agbanyeghị zuru ntụnyere mejupụtara na arụmọrụ na ika ọgwụ, nwere a ala na-eri, ebe ọ bụ na ụlọ ọrụ natara a ikike n'ihi na ha na emeputa, anaghị emefu ego na technology mmepe, ule, na na. N. N'ihi nke a ọ bụ ike ịnọgide na-enwe ya profitability na a ala ala na-emepụta ka ọgwụgwọ.

Dị ka ha na-emekarị ịzụta "Revlimid" (ewere ọgwụ), onye ọrịa nnọọ ike, n'ihi na nke a bụ ụzọ bụ ike overestimate. Onyeikpe maka onwe gị na Swiss ọgwụ "Revlimid" price, Dabere na onunu ogwu, na-amalite site na 270 000 rubles, mgbe ya ọnyà, arụpụtara site Indian ụlọ ọrụ "Natco" efu 55 000 rubles. Ihe dị iche bụ nke ukwuu kwesiri ngosi!

Nakwa dị ka ika-aha ọgwụ ọjọọ, "Revlimid", ego nke nke, N'ezie, ike na-ujo dịnụ Indian analogue nwere ike nye iwu ka online na retail isi Indian ụlọ ọrụ na 5 afọ nke aha WWW.ONKO24.COM. Okwu nke Service - nnweta nke mkpa akwụkwọ, nke nwere ike gosi mkpa a oge a na ọgwụgwọ.

Banyere ụlọ ọrụ Natco Pharma, nke na-amịpụta ọnyà

Indian ụlọ ọrụ Natco Pharma, nke na-amịpụta ọnyà, mara n'ụwa nile. Ọ nwere ya rụzuru na ndị na na ubi nke pharmacology nakwa mgbe nile kọwakwuru ọnụ ọgụgụ nke ndị ọgwụ ọjọọ arụpụtara n'okpuru ikikere.

Ọgwụ ndị na-emepụta site na ike "Natco", gbaara dị na kasị elu na mba ụkpụrụ, gụnyere ISA na UK, nke FDA na US, nakwa dị ka eserese na Germany. Ha bụ ezigbo panacea maka ọtụtụ ndị ọrịa, n'ihi na ihe niile na ngwaahịa ndị "Natko" omume mba ụkpụrụ, ọ nwere n'otu ala na-eri, ma si otú na-enwe ike iji zọpụta ike, na ọbụna dị nnọọ ndụ nke ọtụtụ ndị na-ata ahụhụ site na akwa ọrịa.

egosi

The kọwara nkwadebe ọgwụ na myelodysplastic ọrịamkpokọta, na nchoputa "Multiple myeloma" ọgwụgwọ "Revlimid" nwere ike dị ukwuu ikwado ọrịa na-arịa.

A na-akpọ ọrịa bụ, n'ezie, a akpụ nke dịghịzi usoro plasma mkpụrụ ndụ, nke na-guzobere na ụmị ọkpụkpụ. A n'ikuku "Revlimid" ọnụ na a obere dose steroid "Dexamethasone", nke dabeere na data adade ke American Society of Hematology, kwụsịrị mmepe nke daa ọrịa maka a ogologo oge karịa bụ ikpe na ojiji nke naanị otu "Dexamethasone".

Dị ka na-eji "Revlimid"

The kọwara ngwá ọrụ na-aduak naanị maka onu ochichi. Gelatin capsules ike-ata ma ọ bụ etipịa. Ke ofụri ofụri, na "Revlimid" na ya ọnyà anabata nditịm na ndenye ọgwụ, na ụfọdụ oge, tupu a nri ma ọ bụ ozugbo ya. The Capsule ga-asa ala na mmiri.

Atụmatụ nke ngwa

The amalite dose na-emekarị bụ na 25 mg otu ugboro n'ụbọchị na ụbọchị 1-21 nke ọ bụla 28-ewe ụbọchị. "Dexamethasone", nke na-kenyere ifịk ọgwụ na-ewere 40 mg otu ugboro n'ụbọchị maka 1-4, 9-12 na 17-20 ụbọchị n'ihi na mbụ 4 cycles, wee 40 mg otu ugboro n'ụbọchị maka 1-4 ụbọchị.

N'ihe banyere ọgwụ ekweghị ibe nọrọ nke dose ukpụhọde kwesịrị na rụrụ site na ịga dibịa!

Mmekọrịta ndị ọzọ ọgwụ ọjọọ eme ihe

Mutual mmetụta na metabolism nke ọgwụ ọjọọ ndị ọzọ na lenalidomide ahuru.

Echeta belata irè nke ọnụ na gbochie afọ, natara na kọwara omume, n'ihi ikpughe "Dexamethasone", nke a na-kenyere "Revlimid".

contraindications

Nakwa dị ka "Revlimid", ya analogues na-contraindicated:

• n'oge ime;
• ara;
• ma ọ bụrụ na ọ dị mkpa, iji chebe ịmụ nwa nwere;
• na nwata;
• na butere n'aka lactose ekweghị ibe nọrọ (capsules nwere ya nkwadebe);
• hypersensitivity ka ya mmiri.

mmetụta

Imeso "Revlimid" na ọnyà nwere ike ime ka n'akụkụ mmeghachi omume. Ọtụtụ mgbe ha na-egosi na ụdị:

• neutropenia (39.4%);
• muscle adịghị ike (27.2%);
• asthenia (17.6%);
• ntachi (23.5%);
• muscle cramps (20.1%);
• thrombocytopenia (18.4%);
• anaemia (17%);
• afọ ọsịsa (14.2%);
• ọkụ ọkụ (10.2%).

N'ihi ya, mmepe nke thrombocytopenia na neutropenia nwere kasị ukwuu na nduzi na onunu ogwu nke ọgwụ, ikwe ịchịkwa ndị a Filiks iwetulata ndị dose.